Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869165 · ClinicalTrials.gov registry record · Phase 4
Vaginal and Urinary Microbiome Trial
A Phase 4 study, sponsored by University of Louisville.
- Completed
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT02869165 is a Phase 4 study that has completed, run by University of Louisville. The registered enrollment target is 110 participants.
The verdict
NCT02869165, a Phase 4 study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
A randomized controlled trial looking at the effects of vaginal estrogen and a nonhormonal alternative on the vaginal and urinary microbiome in women with genitourinary syndrome of menopause.
Interventions
- DRUG Conjugated equine estrogen topical cream
- DRUG Apricot kernel oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02869165
The ClinicalTrials.gov registry entry for NCT02869165 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conjugated equine estrogen topical cream is the first listed.
NCT02869165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02869165 about?
NCT02869165 is a clinical study titled "Vaginal and Urinary Microbiome Trial". A randomized controlled trial looking at the effects of vaginal estrogen and a nonhormonal alternative on the vaginal and urinary microbiome in women with genitourinary syndrome of menopause.
What is the current status of trial NCT02869165?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2017-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02869165?
The interventions under investigation include: Conjugated equine estrogen topical cream (DRUG), Apricot kernel oil (DRUG).
Who is sponsoring clinical trial NCT02869165?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.